Partial thromboplastin time

Jump to navigation Jump to search
Partial thromboplastin time

WikiDoc Resources for Partial thromboplastin time

Articles

Most recent articles on Partial thromboplastin time

Most cited articles on Partial thromboplastin time

Review articles on Partial thromboplastin time

Articles on Partial thromboplastin time in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Partial thromboplastin time

Images of Partial thromboplastin time

Photos of Partial thromboplastin time

Podcasts & MP3s on Partial thromboplastin time

Videos on Partial thromboplastin time

Evidence Based Medicine

Cochrane Collaboration on Partial thromboplastin time

Bandolier on Partial thromboplastin time

TRIP on Partial thromboplastin time

Clinical Trials

Ongoing Trials on Partial thromboplastin time at Clinical Trials.gov

Trial results on Partial thromboplastin time

Clinical Trials on Partial thromboplastin time at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Partial thromboplastin time

NICE Guidance on Partial thromboplastin time

NHS PRODIGY Guidance

FDA on Partial thromboplastin time

CDC on Partial thromboplastin time

Books

Books on Partial thromboplastin time

News

Partial thromboplastin time in the news

Be alerted to news on Partial thromboplastin time

News trends on Partial thromboplastin time

Commentary

Blogs on Partial thromboplastin time

Definitions

Definitions of Partial thromboplastin time

Patient Resources / Community

Patient resources on Partial thromboplastin time

Discussion groups on Partial thromboplastin time

Patient Handouts on Partial thromboplastin time

Directions to Hospitals Treating Partial thromboplastin time

Risk calculators and risk factors for Partial thromboplastin time

Healthcare Provider Resources

Symptoms of Partial thromboplastin time

Causes & Risk Factors for Partial thromboplastin time

Diagnostic studies for Partial thromboplastin time

Treatment of Partial thromboplastin time

Continuing Medical Education (CME)

CME Programs on Partial thromboplastin time

International

Partial thromboplastin time en Espanol

Partial thromboplastin time en Francais

Business

Partial thromboplastin time in the Marketplace

Patents on Partial thromboplastin time

Experimental / Informatics

List of terms related to Partial thromboplastin time

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

The partial thromboplastin time (PTT) or activated partial thromboplastin time (aPTT or APTT) is a performance indicator measuring the efficacy of both the "intrinsic" (now referred to as the contact activation pathway) and the common (tissue factor pathway) coagulation pathways. Apart from detecting abnormalities in blood clotting, it is also used to monitor the treatment effects with heparin, a major anticoagulant.

Reference Range
Around 35-55 seconds
Under heparin therapy according to indication: 1.5-2.5x longer
PTT is not prolonged under therapy with low-molecular heparins

Differential Diagnosis

In alphabetical order: [1] [2]

Prolonged

Methodology

Blood is collected, by a phlebotomist, with oxalate or citrate which arrest coagulation by binding calcium. This specimen is delivered to the laboratory. In order to activate the intrinsic pathway, phospholipid, an activator (such as silica, celite, kaolin, ellagic acid), and calcium (to reverse the anticoagulant effect of the oxalate) are mixed into the plasma sample . The time is measured until a thrombus (clot) forms. This testing is performed by a medical technologist.

The test is termed "partial" due to the absence of tissue factor from the reaction mixture.

Interpretation

Values below 25 seconds or over 39 s (depending on local normal ranges) are generally abnormal. Shortening of the PTT has little clinical relevance. Prolonged aPTT may indicate:

To distinguish the above causes, mixing studies are performed, in which the patient's plasma is mixed (initially at a 50:50 dilution) with normal plasma. If the abnormality does not disappear, the sample is said to contain an "inhibitor" (either heparin, antiphospholipid antibodies or coagulation factor specific inhibitors), while if it does correct a factor deficiency is more likely. Deficiencies of factors VIII, IX, XI and XII and rarely von Willebrand factor (if causing a low factor VIII level) may lead to a prolonged aPTT correcting on mixing studies.

History

The aPTT was first described in 1953.[3]

See also

References

  1. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016
  2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X
  3. Langdell RD, Wagner RH, Brinkhous KM (1953). "Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure". J. Lab. Clin. Med. 41 (4): 637–47. PMID 13045017.


cs:Aktivovaný parciální tromboplastinový čas de:Partial Thromboplastin Time it:Tempo di Tromboplastina nl:Geactiveerde partiële tromboplastinetijd

Template:WH Template:WS